4.4 Article

Cytogenetic Analysis of False-Positive Mucosa by Photodynamic Diagnosis Using 5-Aminolevulinic Acid - Possible Existence of Premalignant Genomic Alterations Examined by in vitro Experiment

Journal

ONCOLOGY
Volume 76, Issue 2, Pages 118-125

Publisher

KARGER
DOI: 10.1159/000195537

Keywords

Bladder cancer; Chromosome 9; Chromosomal instability; 5-Aminolevulinic acid; Numerical chromosomal aberrations; Photodynamic diagnosis

Categories

Funding

  1. Japanese Foundation for Research and Promotion of Endoscopy

Ask authors/readers for more resources

Objective: Although photodynamic diagnosis is a powerful tool for the detection of flat urothelial tumors, false-positive fluorescent mucosa still requires further elucidation. Thus, we aimed to study the significance of nonmalignant fluorescent mucosa by a cytogenetic approach. Methods: Sixty specimens of bladder mucosa were collected from 20 patients who were suspected of having carcinoma in situ by fluorescence cystoscopy with 5-aminolevulinic acid. To detect the copy number aberrations, the multi-color fluorescence in situ hybridization technique was performed, and the variant fractions ( total fractions other than those of the modal copy number) of chromosomes 7, 9 and 17 and the chromosomal instability were determined. To delineate the relevant gene to the fluorescent mucosa, a comparative genomic hybridization technique was applied for 8 established bladder cancer cell lines, and these results were compared with the in vitro fluorescent expression experiment. Results: Fluorescent mucosa was detected in 33 of the 34 malignant tissue specimens ( 16 carcinoma in situ, 18 other transitional cell carcinomas) and in 11 of the 26 nonmalignant tissue specimens ( 6 dysplasia, 20 normal mucosa), with a false-positive rate of 42.3%. The variant fraction of chromosome 9 was significantly higher in fluorescent than in non-fluorescent mucosa, not only for all tissues ( 33 vs. 17%; p = 0.0069), but also for nonmalignant tissues ( 28 vs. 15%; p = 0.0225). There was no alteration in chromosome 9 in 1 cell line without fluorescent mucosa, while 5 of the 7 cell lines with fluorescent mucosa had a common deleted region on 9q24.1. Conclusion: These data suggest that a substantial portion of nonmalignant fluorescent mucosa harbors alterations in chromosome 9. Copyright (C) 2009 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: Comparative outcomes

Koji Shiraishi, Seiji Kitahara, Hideaki Ito, Kazuo Oba, Chietaka Ohmi, Hideyasu Matsuyama

INTERNATIONAL JOURNAL OF UROLOGY (2019)

Meeting Abstract Oncology

The role of adjuvant chemotherapy for pT2-4 upper urinary tract urothelial cancer: Exploratory analysis of large multi-institutional study (JCOG1110A).

Junichi Inokuchi, Kentaro Kuroiwa, Hiroyuki Nishiyama, Takahiro Kojima, Yoshiyuki Kakehi, Mikio Sugimoto, Toshiki Tanikawa, Hiroyuki Fujimoto, Momokazu Gotoh, Naoya Masumori, Osamu Ogawa, Masatoshi Eto, Chikara Ohyama, Akito Yamaguchi, Hideyasu Matsuyama, Tomohiko Ichikawa, Keiichi Ito, Junki Mizusawa, Junko Eba, Seiji Naito

JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Oncology

Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma

Shuji Mikami, Ryuichi Mizuno, Tsunenori Kondo, Nobuo Shinohara, Norio Nonomura, Seiichiro Ozono, Masatoshi Eto, Katsunori Tatsugami, Tatsuya Takayama, Hideyasu Matsuyama, Takeshi Kishida, Mototsugu Oya

CANCER SCIENCE (2019)

Article Medicine, General & Internal

Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer

Shinichi Sakamoto, Maihulan Maimaiti, Minhui Xu, Shuhei Kamada, Yasutaka Yamada, Hiroki Kitoh, Hiroaki Matsumoto, Nobuyoshi Takeuchi, Kosuke Higuchi, Haruhito A. Uchida, Akira Komiya, Maki Nagata, Hiroomi Nakatsu, Hideyasu Matsuyama, Koichiro Akakura, Tomohiko Ichikawa

JOURNAL OF CLINICAL MEDICINE (2019)

Article Urology & Nephrology

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Kentaro Kuroiwa, Junichi Inokuchi, Hiroyuki Nishiyama, Takahiro Kojima, Yoshiyuki Kakehi, Mikio Sugimoto, Toshiki Tanigawa, Hiroyuki Fujimoto, Momokazu Gotoh, Naoya Masumori, Osamu Ogawa, Masatoshi Eto, Chikara Ohyama, Akira Yokomizo, Hideyasu Matsuyama, Tomohiko Ichikawa, Junki Mizusawa, Junko Eba, Seiji Naito, N. Shinohara, A. Ito, S. Kawamura, T. Habuchi, N. Tsuchiya, K. Ito, S. Egawa, T. Nakagawa, M. Iwamura, O. Ishi-Zuka, H. Miyake, M. Niwakawa, Y. Sugimura, K. Nishumura, K. Fujimoto, A. Takenaka, K. Hashine, T. Kamba

JOURNAL OF UROLOGY (2019)

Article Pharmacology & Pharmacy

Pharmacokinetics of Neoadjuvant Axitinib Influenced the Efficacy in Patients With Advanced Renal Cell Carcinoma

Yoshiaki Yamamoto, Toru Otori, Ryo Inoue, Seiji Yano, Hiroshi Hirata, Hiroaki Matsumoto, Kenji Matsuyama, Hideyasu Matsuyama

JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Article Urology & Nephrology

Transcriptome Analysis to Identify Human Spermatogonial Cells from Sertoli Cell-Only Testes

Koji Shiraishi, Masanori Tabara, Hideyasu Matsuyama

JOURNAL OF UROLOGY (2020)

Article Oncology

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer

Masaki Shiota, Naohiro Fujimoto, Yoshiaki Yamamoto, Ario Takeuchi, Katsunori Tatsugami, Takeshi Uchiumi, Hideyasu Matsuyama, Masatoshi Eto

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Article Urology & Nephrology

The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients

Kimihiko Nakamura, Yudai Nagata, Toshiya Hiroyoshi, Naohito Isoyama, Koki Fujikawa, Yutaka Miura, Hideyasu Matsuyama, Makoto Kuro-o

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)

Article Oncology

Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan

Atsushi Ikeda, Takahiro Kojima, Koji Kawai, Shiro Hinotsu, Naoto Keino, Kenichiro Shiga, Hideaki Miyake, Yasuyoshi Miyata, Yutaka Enomoto, Fumitaka Shimizu, Satoshi Anai, Hideyasu Matsuyama, Chieko Suzuki, Yusuke Kanimoto, Keisuke Shigeta, Seiji Naito, Hideyuki Akaza, Hiroyuki Nishiyama

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Immunology

Receptor activator of the NFκB ligand system protects renal function during experimental renal ischemia-reperfusion in mice

Yuki Nakayama, Naohito Isoyama, Takeshi Yamamoto, Yudai Nagata, Masafumi Matsumura, Koki Fujikawa, Hideyasu Matsuyama, Koji Shiraishi

TRANSPLANT IMMUNOLOGY (2020)

Article Medicine, General & Internal

Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma

Makito Miyake, Nagaaki Marugami, Yuya Fujiwara, Kazumasa Komura, Teruo Inamoto, Haruhito Azuma, Hiroaki Matsumoto, Hideyasu Matsuyama, Kiyohide Fujimoto

DIAGNOSTICS (2020)

Article Oncology

A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables

Makito Miyake, Hideyasu Matsuyama, Satoshi Teramukai, Fumie Kinoshita, Isao Yokota, Hiroaki Matsumoto, Keiji Shimada, Mitsuru Kinjyo, Tatsuro Shimokama, Koji Okumura, Masaya Yomenori, Hideki Enokida, Masayuki Nakagawa, Yasushi Nakai, Kiyohide Fujimoto

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma

Yoshiaki Yamamoto, Hideyasu Matsuyama, Hiroaki Matsumoto, Shigeru Sakano, Nakanori Fuji, Kazuo Oba, Mitsutaka Yamamoto, Yoriaki Kamiryo, Takeshi Hiragino, Kazuhiro Nagao, Kimio Takai, Akihiko Aoki

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)

No Data Available